TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3304988

Group type: EXPERIMENTAL
Intervention: 3.2 mm bipolar diathermy probe
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (not specified treatment)
Number of subjects: 44
Study: 29979803

Group type: EXPERIMENTAL
Intervention: Oxycodone and acetaminophen PRN
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Oxycodone and acetaminophen with specific dosing
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Oxycodone, acetaminophen, and OxyContin with specific dosing
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Oxycodone, acetaminophen, and ketorolac with specific dosing
Number of subjects: 79
Study: 26190830

Group type: EXPERIMENTAL
Intervention: Subcutaneous agar‐filled needle with calomel (Ndl)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Dermal abrasion with conducting cream and Ag/AgCl electrodes (Abr)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Both methods (Ndl and Abr)
Number of subjects: 29
Study: 24636266

Group type: EXPERIMENTAL
Intervention: Procalcitonin-guided antibiotic therapy
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard guidelines for antibiotic therapy (Control)
Number of subjects: 105
Study: 22120765

Group type: EXPERIMENTAL
Intervention: Nebulized L-epinephrine 0.5 ml
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Nebulized L-epinephrine 2.5 ml
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Nebulized L-epinephrine 5 ml
Number of subjects: 96
Study: 20679654

Group type: EXPERIMENTAL
Intervention: Enrollment in the Oregon Medicaid program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list for Oregon Medicaid program
Number of subjects: 0
Study: 18653305

Group type: EXPERIMENTAL
Intervention: Structured education
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Steps per day
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 103
Study: 16284031

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risk-stratified approach
Number of subjects: 0
Study: 12187023

Group type: EXPERIMENTAL
Intervention: Interferon gamma-1b (IFN-gamma), given subcutaneously at a dose of 50 microg/m(2) daily for 30 days.
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 10703408

Group type: EXPERIMENTAL
Intervention: Maternal Care manual of the Perinatal Education Programme (PEP)
Number of subjects: 0
Study: 8697717

Group type: EXPERIMENTAL
Intervention: High carbohydrate meal (2.5 MJ)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: High fat meal (2.5 MJ)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both meals
Number of subjects: 9

Group type: COMPARATOR
Intervention: Healthy age-matched control subjects
Number of subjects: 9
Study: 1767176

Group type: EXPERIMENTAL
Intervention: Troxerutin (4 g/d)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 6753447

Group type: EXPERIMENTAL
Intervention: dl-propranolol
Number of subjects: 24

Group type: COMPARATOR
Intervention: d-propranolol
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study: 31140666

Group type: EXPERIMENTAL
Intervention: Stereotype threat message
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control message
Number of subjects: 77
Study: 29210845

Group type: EXPERIMENTAL
Intervention: Deep hypnosis session
Number of subjects: 66

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 66
Study: 27315354

Group type: EXPERIMENTAL
Intervention: truth FinishIt brand equity scale
Number of subjects: 0
Study: 25162332

Group type: EXPERIMENTAL
Intervention: Fiber-reinforced composite retainer
Number of subjects: 30

Group type: COMPARATOR
Intervention: Spiral wire retainer
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Radiographic examination
Number of subjects: 30
Study: 22819265

Group type: EXPERIMENTAL
Intervention: Clopidogrel (300 mg loading dose)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (300 mg loading dose)
Number of subjects: 60
Study: 19914566

Group type: EXPERIMENTAL
Intervention: Fluorouracil (5-FU) based adjuvant chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 0
Study: 18091485

Group type: EXPERIMENTAL
Intervention: Multidisciplinary lifestyle interventions for hypertension
Number of subjects: 731

Group type: COMPARATOR
Intervention: Routine care in occupational or primary healthcare services
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: Multidisciplinary lifestyle interventions for hypertension (subgroup analysis)
Number of subjects: 731
Study: 16296924

Group type: EXPERIMENTAL
Intervention: Kampo therapy for 12 weeks
Number of subjects: 173
Study: 12027847

Group type: EXPERIMENTAL
Intervention: +20 cmH(2)O
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: +30 cmH(2)O
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: MBAME
Number of subjects: 11
Study: 10726112

Group type: EXPERIMENTAL
Intervention: Terazosin
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 8824645

Group type: EXPERIMENTAL
Intervention: Lactose (1 cup of milk)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lactose-hydrolyzed control (1 cup of milk)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactose (1 L of milk)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pre-hydrolyzed milk and lactase preparations
Number of subjects: 0
Study: 1775676

Group type: EXPERIMENTAL
Intervention: Controlled release salbutamol (SCR) 8 mg twice daily for 6 weeks
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 7318626

Group type: EXPERIMENTAL
Intervention: Cefamandole treatment in 112 patients
Number of subjects: 457

Group type: COMPARATOR
Intervention: Neomycin-erythromycin combined with cephalothin in 151 patients
Number of subjects: 457

Group type: COMPARATOR
Intervention: Matched control patients (141 patients)
Number of subjects: 457
Study: 31395808

Group type: EXPERIMENTAL
Intervention: Animal-assisted therapy (kinesitherapy with therapy dog)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Kinesitherapy (without therapy dog)
Number of subjects: 52
Study: 28237053

Group type: EXPERIMENTAL
Intervention: Ecological momentary assessment (EMA) text messages
Number of subjects: 30
Study: 26348788

Group type: EXPERIMENTAL
Intervention: OMSC+Performance Coaching Group
Number of subjects: 0

Group type: COMPARATOR
Intervention: OMSC Group
Number of subjects: 0
Study: 23799706

Group type: EXPERIMENTAL
Intervention: iWell OSN
Number of subjects: 349

Group type: COMPARATOR
Intervention: Control
Number of subjects: 349
Study: 21836369

Group type: EXPERIMENTAL
Intervention: 120 minutes intensive resistance program at 70%-80% of 1RM
Number of subjects: 34
Study: 19299682

Group type: EXPERIMENTAL
Intervention: Aerobic conditioning
Number of subjects: 149

Group type: COMPARATOR
Intervention: Strength training
Number of subjects: 149
Study: 17582255

Group type: EXPERIMENTAL
Intervention: Esomeprazole-based 1 week triple therapy
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Esomeprazole-based 2 weeks triple therapy
Number of subjects: 105
Study: 15636562

Group type: EXPERIMENTAL
Intervention: Prestige II Cervical Disc
Number of subjects: 55

Group type: COMPARATOR
Intervention: Iliac crest autograft fusion
Number of subjects: 55
Study: 16154059

Group type: EXPERIMENTAL
Intervention: Rose tea
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 130
Study: 10690135

Group type: EXPERIMENTAL
Intervention: Sevoflurane anaesthesia
Number of subjects: 30

Group type: COMPARATOR
Intervention: Propofol anaesthesia
Number of subjects: 30
Study: 8912799

Group type: EXPERIMENTAL
Intervention: Ritanserin
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 1907549

Group type: EXPERIMENTAL
Intervention: Piroxicam, 20 mg day‐1
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 6870379

Group type: EXPERIMENTAL
Intervention: Halsted radical mastectomy
Number of subjects: 311

Group type: COMPARATOR
Intervention: Modified radical mastectomy
Number of subjects: 311
Study: 30776457

Group type: EXPERIMENTAL
Intervention: smartphone application (PocketCPR)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: dispatcher-assisted telephone CPR
Number of subjects: 100

Group type: COMPARATOR
Intervention: uninstructed CPR
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: dispatcher-assisted telephone CPR combined with smartphone app
Number of subjects: 100
Study: 28629397

Group type: EXPERIMENTAL
Intervention: Early initiation of renal replacement therapy (RRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Late initiation of renal replacement therapy (RRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sensitive biomarker panel for AKI diagnosis
Number of subjects: 0
Study: 26926372

Group type: EXPERIMENTAL
Intervention: Recombinant human thrombopoietin (rhTPO) combined with high-dose dexamethasone (40 mg intravenously d1-4) and rhTPO (300 U·kg(‐1)·d(‐1) subcutaneously d1-14)
Number of subjects: 59

Group type: COMPARATOR
Intervention: High-dose dexamethasone (40 mg intravenously d1-4)
Number of subjects: 59
Study: 24570273

Group type: EXPERIMENTAL
Intervention: Tart cherry juice concentrate (30 ml diluted to 250 ml with water)
Number of subjects: 47
Study: 22563640

Group type: EXPERIMENTAL
Intervention: Live supervision via tele-conferencing (TCS)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Standard tape-based supervision (Tape)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Workshop training alone
Number of subjects: 58
Study: 19495957

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17301566

Group type: EXPERIMENTAL
Intervention: peginterferon and ribavirin
Number of subjects: 35

Group type: COMPARATOR
Intervention: standard interferon and ribavirin
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: HCV RNA < 50 IU/ml at week 4
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: HCV RNA < 600 IU/ml at week 4
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: HCV RNA > 50 IU/ml at week 4
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: HCV RNA > 600 IU/ml at week 4
Number of subjects: 35
Study: 15060416

Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch 200/0.5
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4% modified gelatine
Number of subjects: 0
Study: 11585082

Group type: EXPERIMENTAL
Intervention: Cisapride (0.2 mg/kg every 8 h)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 9827406

Group type: EXPERIMENTAL
Intervention: D-Dimer test with a cutoff value below 2 micrograms/ml
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: D-Dimer test with a cutoff value over 4 micrograms/ml
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: D-Dimer test results correlation
Number of subjects: 103
Study: 8003650

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 29417832

Group type: COMPARATOR
Intervention: Supervised group-based exercise (Group B)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Internet-based exercise (Group C)
Number of subjects: 65
Study: 28511647

Group type: EXPERIMENTAL
Intervention: Improved cookstove (low‐smoke chulha)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Traditional cookstove (chulha) or a combination of traditional stove and kerosene/diesel stove
Number of subjects: 250
Study: 24303810

Group type: EXPERIMENTAL
Intervention: Traditional Behavioral Couples Therapy (TBCT)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Integrative Behavioral Couples Therapy (IBCT)
Number of subjects: 134
Study: 23715755

Group type: EXPERIMENTAL
Intervention: Short sleep duration (less than 6.5 h, n=21)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Longer sleep duration (above 6.5 h, n=58)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Nondipping pattern of blood pressure
Number of subjects: 79
Study: 20921876

Group type: EXPERIMENTAL
Intervention: ADAS-cog12 (including delayed recall)
Number of subjects: 370

Group type: COMPARATOR
Intervention: ADAS-cog11 (standard 11-item scale)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Delayed Recall (DR) assessment
Number of subjects: 370
Study: 19169599

Group type: EXPERIMENTAL
Intervention: SenseWear Armband
Number of subjects: 21

Group type: COMPARATOR
Intervention: Factorial Method
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Spearman's Correlation
Number of subjects: 21
Study: 16497510

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 12072

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 12072
Study: 12553852

Group type: EXPERIMENTAL
Intervention: alefacept (0.025, 0.075, or 0.150 mg/kg)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: alefacept
Number of subjects: 229

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 229
Study: 10674226

Group type: EXPERIMENTAL
Intervention: Nutritional intervention (daily distribution of two oral supplements, each containing 200 kcal for 15 days)
Number of subjects: 672

Group type: COMPARATOR
Intervention: Control group (no nutritional intervention)
Number of subjects: 672
Study: 9075033

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine with 1:200,000 epinephrine plus 30 micrograms/kg butorphanol (Group 2)
Number of subjects: 200

Group type: COMPARATOR
Intervention: 0.25% bupivacaine with 1:200,000 epinephrine (Group 1)
Number of subjects: 200
Study: 8369008

Group type: EXPERIMENTAL
Intervention: Vitex agnus castus preparation (20 mg daily)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 2878676

Group type: EXPERIMENTAL
Intervention: Oral xamoterol (200 mg twice daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31948296

Group type: EXPERIMENTAL
Intervention: S-ketamine
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Racemic ketamine
Number of subjects: 303

Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 303
Study: 29912350

Group type: EXPERIMENTAL
Intervention: iReadMore training with anodal transcranial direct current stimulation
Number of subjects: 21

Group type: COMPARATOR
Intervention: iReadMore training with sham stimulation
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: iReadMore training
Number of subjects: 21
Study: 26992050

Group type: EXPERIMENTAL
Intervention: FVOO (500 ppm)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: FVOOT (250 ppm olive oil polyphenols and 250 ppm thyme polyphenols)
Number of subjects: 33

Group type: COMPARATOR
Intervention: VOO (standard virgin olive oil)
Number of subjects: 33
Study: 24974387

Group type: EXPERIMENTAL
Intervention: 1,000 U of vitamin D3
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 2,000 U of vitamin D3
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 4,000 U of vitamin D3
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 21786130

Group type: EXPERIMENTAL
Intervention: 1.0-2.0 Gz intermittent artificial gravity with 40 W of ergometric workload every day (countermeasure group, CM)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 12
Study: 20623037

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 23
Study: 18162494

Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 342

Group type: COMPARATOR
Intervention: Advanced Moist Wound Therapy (AMWT)
Number of subjects: 342
Study: 16398603

Group type: EXPERIMENTAL
Intervention: Roll-stretch massage
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Shiatsu massage
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Beat massage
Number of subjects: 10

Group type: COMPARATOR
Intervention: No massage (control condition)
Number of subjects: 10
Study: 12404666

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 0
Study: 10367991

Group type: EXPERIMENTAL
Intervention: I2‐imidazoline receptor density in ATD patients (8.4 and 14.3 fmol/mg protein)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: MAO‐B activity in ATD patients
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Correlation between I2‐imidazoline receptors and MAO‐B activity
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cognitive evaluation by Mini‐Mental State Examination
Number of subjects: 20
Study: 7884434

Group type: EXPERIMENTAL
Intervention: Amonafide (300 mg/m2 daily for 5 days)
Number of subjects: 73
Study: 1696799

Group type: EXPERIMENTAL
Intervention: Hirudoid cream
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Piroxicam gel
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 7458751

Group type: EXPERIMENTAL
Intervention: Various chemical agents administered to influence microcirculation and metabolism of the inner ear.
Number of subjects: 209

Group type: COMPARATOR
Intervention: NaCl infusions and glucose tablets (control group).
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Polypragmatic therapy (four different forms).
Number of subjects: 209
Study: 31642928

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavior therapy for 16 weeks
Number of subjects: 152

Group type: COMPARATOR
Intervention: Face-to-face cognitive behavior therapy for 16 weeks
Number of subjects: 152
Study: 29470571

Group type: EXPERIMENTAL
Intervention: MOG‐IgG positive patients (3 patients, 1.7%)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: AQP4‐IgG
Number of subjects: 177
Study: 26830029

Group type: EXPERIMENTAL
Intervention: Enhanced psychological care (nurse‐led mental health care coordination and behavioural activation)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Routine cardiac rehabilitation programmes alone (Control)
Number of subjects: 64
Study: 24440324

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) in high-income countries
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Primary percutaneous coronary intervention in ST elevation myocardial infarction (STEMI) patients from high-income countries
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Evidence-based medications at discharge in high-income countries
Number of subjects: 392
Study: 22523593

Group type: EXPERIMENTAL
Intervention: 1,2-octanediol lotion (20% alcohol) applied for 2-2.5 hours
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: 1,2-octanediol lotion (20% alcohol) applied for 8 hours/overnight
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: 1,2-octanediol alcohol free mousse applied for 8 hours/overnight
Number of subjects: 641

Group type: COMPARATOR
Intervention: 0.5% malathion
Number of subjects: 641
Study: 20673378

Group type: COMPARATOR
Intervention: Control diet + placebo capsules
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 20 mmol K(+)/d from fruit and vegetables
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 40 mmol K(+)/d from fruit and vegetables
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 40 mmol potassium citrate capsules/d
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: All diets (including control)
Number of subjects: 57
Study: 18159577

Group type: EXPERIMENTAL
Intervention: Intravenous morphine administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Epidural morphine administration
Number of subjects: 0
Study: 16115933

Group type: EXPERIMENTAL
Intervention: Doxil (40 mg/m2 i.v. on day 1) and continuous infusion topotecan (0.4 mg/m2/day for 14 days)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Oral topotecan (0.4 mg/m2 bid for 14 days)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Doxil with 14‐day topotecan infusion
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Doxil and continuous infusion topotecan
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Clinical benefit (objective responses and stable diseases)
Number of subjects: 57
Study: 12392587

Group type: EXPERIMENTAL
Intervention: Cerivastatin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10200009

Group type: EXPERIMENTAL
Intervention: Active immunotherapy (cat/dust mite)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (placebo-pollen)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both groups (active immunotherapy and placebo)
Number of subjects: 29
Study: 8541370

Group type: EXPERIMENTAL
Intervention: Colonoscopy (CS)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Simple contrast barium enema (SCBE)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Barium enema + rectosigmoidoscopy (BERS)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Barium enema (general)
Number of subjects: 67
Study: 2108586

Group type: EXPERIMENTAL
Intervention: Enclosed Magill breathing system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bain breathing system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Humphrey ADE breathing system
Number of subjects: 0
Study: 6796106

Group type: EXPERIMENTAL
Intervention: Continuous oral cyclophosphamide (arm S)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Combination of oral cyclophosphamide, hexamethylmelamine and methotrexate on a pulsed basis (arm T)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Both arms (S and T)
Number of subjects: 264
Study: 31467422

Group type: EXPERIMENTAL
Intervention: VIG
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: MOD
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: BIKE
Number of subjects: 88

Group type: COMPARATOR
Intervention: CON
Number of subjects: 88
Study: 29544651

Group type: EXPERIMENTAL
Intervention: Leadership team (administrator/educator) year-long interventions
Number of subjects: 8150

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 8150
Study: 27124881

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab monotherapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Dexamethasone delayed delivery system monotherapy
Number of subjects: 50
Study: 24535625

Group type: EXPERIMENTAL
Intervention: Luseogliflozin (1-25 mg single dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Luseogliflozin (5 or 10 mg/day for 7 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0